Baseline — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Gildgild.com in 𝕏Jun 2014 · $13.5MAcquired

Gilead is a biopharmaceutical company that develops medicines across virology, oncology, and inflammation, with over 25 medicines offered globally and 53 clinical programs.

BiotechHealthtech

Co-investorsBaseline Ventures Globespan Capital Partners Milliways Ventures Correlation Ventures Drive Capital Menlo Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.